Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|March 16, 2010
Incidentally proven pulmonary "ALKoma"Atsushi Osoegawa, Kaname Nosaki, Hitoshi Miyamoto, et al.Leukemia Research|June 23, 2006
Identification of a constitutively active mutant of JAK3 by retroviral expression screeningYoung Lim Choi, Ruri Kaneda, Tomoaki Wada, et al.Scientific Reports|May 23, 2015
Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defectsOsamu Hashizume, Sakiko Ohnishi, Takayuki Mito, et al.Nature|October 17, 2008
Oncogenic mutations of ALK kinase in neuroblastomaYuyan Chen, Junko Takita, Young Lim Choi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcriptsKengo Takeuchi, Young Lim Choi, Manabu Soda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancersKentaro Inamura, Kengo Takeuchi, Yuki Togashi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancerKengo Takeuchi, Young Lim Choi, Yuki Togashi, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 24, 2009
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onsetKentaro Inamura, Kengo Takeuchi, Yuki Togashi, et al.The New England Journal of Medicine|October 29, 2010
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitorsYoung Lim Choi, Manabu Soda, Yoshihiro Yamashita, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2012
A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancerManabu Soda, Kazutoshi Isobe, Akira Inoue, et al.Pageof 6